CVE-2023-33363: Supremainc Biostar 2

High severity, CVSS 7.5. EPSS: 0.6% chance of exploitation in the next 30 days.

An authentication bypass vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated users to access some functionality on BioStar 2 servers.

Affected products

• Supremainc Biostar 2: before 2.9.1 (fixed in 2.9.1)

Published 2023-08-03. Last modified 2026-06-17.